CoChat

Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables

Open access
Ji, Li-Nong, Lu, Ju-Ming, Guo, Xiao-Hui, Yang, Wen-Ying, Weng, Jian-Ping, Jia, Wei-Ping, Zou, Da-Jin, Zhou, Zhi-Guang, Yu, De-Min, Liu, Jie, Shan, Zhong-Yan, Yang, Yu-Zhi, Hu, Ren-Ming, Zhu, Da-Long, Yang, Li-Yong, Chen, Li, Zhao, Zhi-Gang, Li, Qi-Fu, Tian, Hao-Ming, Ji, Qiu-He, Liu, Jing, Ge, Jia-Pu, Shi, Li-Xin, Xu, Yan-Cheng · 2013 · BMC Public Health
Cited by 142

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The prevalence of type 2 diabetes mellitus (T2DM) is increasing rapidly among Chinese adults, and limited data are available on T2DM management and the status of glycemic control in China. We assessed the efficacy of oral antidiabetes drugs (OADs), glucagon-like peptide-1 (GLP-1) receptor agonists, and insulin for treatment of T2DM across multiple regions in China. METHODS: This was a multicenter, cross-sectional survey of outpatients conducted in 606 hospitals across China. Data from all the patients were collected between April and June, 2011. RESULTS: A total of 238,639 patients were included in the survey. Eligible patients were treated with either OADs alone (n=157,212 [65.88%]), OADs plus insulin (n=80,973 [33.93%]), or OADs plus GLP-1 receptor agonists (n=454 [0.19%]). The OAD monotherapy, OAD + insulin, and OAD + GLP-1 receptor agonist groups had mean glycosylated hemoglobin (HbA1c) levels (±SD) of 7.67% (±1.58%), 8.21% (±1.91%), and 7.80% (±1.76%), respectively. Among those three groups, 34.63%, 26.21%, and 36.12% met the goal of HbA1c <7.0%, respectively. Mean HbA1c and achievement of A1c <7.0% was related to the duration of T2DM. CONCLUSIONS: Less than one third of the patients had achieved the goal of HbA1c <7.0%. Glycemic control decreased and insulin use increased with the duration of diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2458-13-602

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 142

Metadata

Authors
Ji, L.-N., Lu, J.-M., Guo, X.-H., Yang, W.-Y., Weng, J.-P., Jia, W.-P., Zou, D.-J., Zhou, Z.-G., Yu, D.-M., Liu, J., Shan, Z.-Y., Yang, Y.-Z., Hu, R.-M., Zhu, D.-L., Yang, L.-Y., Chen, L., Zhao, Z.-G., Li, Q.-F., Tian, H.-M., Ji, Q.-H., Liu, J., Ge, J.-P., Shi, L.-X., & Xu, Y.-C.
Venue
BMC Public Health
Published
2013-06-21
Volume
13
Issue
1
Pages
602-602
ISSN
1471-2458 (ISSN-L)
OpenAlex
W2036709932
Cited by
142
References
5
FWCI
9.43
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables. https://app.cochat.ai/papers/10.1186/1471-2458-13-602
The paper
Ji, L.-N., Lu, J.-M., Guo, X.-H., Yang, W.-Y., Weng, J.-P., Jia, W.-P., Zou, D.-J., Zhou, Z.-G., Yu, D.-M., Liu, J., Shan, Z.-Y., Yang, Y.-Z., Hu, R.-M., Zhu, D.-L., Yang, L.-Y., Chen, L., Zhao, Z.-G., Li, Q.-F., Tian, H.-M., . . . Xu, Y.-C. (2013). Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables. BMC Public Health. https://doi.org/10.1186/1471-2458-13-602

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.